Omalizumab Retreatment of Patients swith Chronic Idopathic Urticaria/Spontaneous Urticaria (CIU/CSU) Following Return of Symptoms: Primary Results of the OPTIMA Study. (2017). SKIN The Journal of Cutaneous Medicine, 1(3.1), s127. https://doi.org/10.25251/skin.1.supp.126